Page last updated: 2024-09-03

3-iodo-alpha-methyltyrosine and probenecid

3-iodo-alpha-methyltyrosine has been researched along with probenecid in 2 studies

Compound Research Comparison

Studies (3-iodo-alpha-methyltyrosine)	Trials (3-iodo-alpha-methyltyrosine)	Recent Studies (post-2010) (3-iodo-alpha-methyltyrosine)	Studies (probenecid)	Trials (probenecid)	Recent Studies (post-2010) (probenecid)
83	9	1	3,664	292	375

Protein Interaction Comparison

Protein	Taxonomy	probenecid (IC50)
Solute carrier family 22 member 8	Mus musculus (house mouse)	3.02
Solute carrier family 22 member 6	Homo sapiens (human)	6.85
Solute carrier family 22 member 8	Homo sapiens (human)	6.965
Solute carrier family 22 member 8	Rattus norvegicus (Norway rat)	6.03

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Flores, LG; Ishikawa, N; Kawai, K; Kubodera, A; Kubota, N; Nishii, R; Shikano, N	1
Ishikawa, N; Iwamura, Y; Kawai, K; Kotani, T; Kubota, N; Nakajima, S; Nishii, R; Ogura, M; Shikano, N; Yamaguchi, N; Yoshimoto, M	1

Other Studies

2 other study(ies) available for 3-iodo-alpha-methyltyrosine and probenecid

Article	Year
An artificial amino acid, 4-iodo-L-meta-tyrosine: biodistribution and excretion via kidney. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:4 Topics: Amino Acids; Animals; Autoradiography; Carbon Radioisotopes; Cell Line; Epithelial Cells; Feasibility Studies; Female; Injections, Intravenous; Iodine Radioisotopes; Kidney; Methyltyrosines; Mice; Mice, Inbred Strains; Organ Specificity; Probenecid; Sensitivity and Specificity; Swine; Tissue Distribution; Tyrosine	2003
Pharmacokinetics of 3-[125I]iodo-alpha-methyl-L-tyrosine, a tumor imaging agent, after probenecid loading in mice implanted with colon cancer DLD-1 cells. Nuclear medicine and biology, 2007, Volume: 34, Issue:8 Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Kidney; Male; Metabolic Clearance Rate; Methyltyrosines; Mice; Organ Specificity; Probenecid; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Uricosuric Agents	2007

Article

Year

An artificial amino acid, 4-iodo-L-meta-tyrosine: biodistribution and excretion via kidney.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2003, Volume: 44, Issue:4

Topics: Amino Acids; Animals; Autoradiography; Carbon Radioisotopes; Cell Line; Epithelial Cells; Feasibility Studies; Female; Injections, Intravenous; Iodine Radioisotopes; Kidney; Methyltyrosines; Mice; Mice, Inbred Strains; Organ Specificity; Probenecid; Sensitivity and Specificity; Swine; Tissue Distribution; Tyrosine

2003

Pharmacokinetics of 3-[125I]iodo-alpha-methyl-L-tyrosine, a tumor imaging agent, after probenecid loading in mice implanted with colon cancer DLD-1 cells.

Nuclear medicine and biology, 2007, Volume: 34, Issue:8

Topics: Animals; Cell Line, Tumor; Colonic Neoplasms; Kidney; Male; Metabolic Clearance Rate; Methyltyrosines; Mice; Organ Specificity; Probenecid; Radionuclide Imaging; Radiopharmaceuticals; Tissue Distribution; Uricosuric Agents

2007